Total Payments
$1,310
2024 Payments
$115.60
Companies
10
Transactions
25
Medicare Patients
11,735
Medicare Billing
$1.1M
Payment Breakdown by Category
Education$754.97 (57.6%)
Food & Beverage$555.05 (42.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $754.97 | 8 | 57.6% |
| Food and Beverage | $555.05 | 17 | 42.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $754.97 | 8 | $0 (2024) |
| MERZ NORTH AMERICA, INC. | $207.23 | 2 | $0 (2021) |
| PFIZER INC. | $116.81 | 1 | $0 (2017) |
| VYNE Pharmaceuticals Inc. | $88.39 | 6 | $0 (2021) |
| AbbVie, Inc. | $57.11 | 3 | $0 (2019) |
| Galderma Laboratories, L.P. | $22.04 | 1 | $0 (2019) |
| Allergan Inc. | $21.19 | 1 | $0 (2018) |
| Astellas Pharma US Inc | $16.60 | 1 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $13.78 | 1 | $0 (2018) |
| LEO Pharma Inc. | $11.90 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $115.60 | 2 | Janssen Biotech, Inc. ($99.00) |
| 2023 | $99.00 | 1 | Janssen Biotech, Inc. ($99.00) |
| 2022 | $99.00 | 1 | Janssen Biotech, Inc. ($99.00) |
| 2021 | $135.57 | 3 | Janssen Biotech, Inc. ($79.99) |
| 2020 | $188.09 | 7 | Janssen Biotech, Inc. ($99.00) |
| 2019 | $124.15 | 3 | Janssen Biotech, Inc. ($79.99) |
| 2018 | $297.81 | 4 | Merz North America, Inc. ($162.85) |
| 2017 | $250.80 | 4 | PFIZER INC. ($116.81) |
All Payment Transactions
25 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $99.00 | General |
| Category: Immunology | ||||||
| 02/05/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: Oncology | ||||||
| 03/15/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $99.00 | General |
| Category: Immunology | ||||||
| 07/28/2022 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $99.00 | General |
| Category: Immunology | ||||||
| 07/21/2021 | MERZ NORTH AMERICA, INC. | — | Food and Beverage | In-kind items and services | $44.38 | General |
| 03/22/2021 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $79.99 | General |
| Category: Immunology | ||||||
| 01/05/2021 | VYNE Pharmaceuticals Inc. | AMZEEQ (Drug) | Food and Beverage | In-kind items and services | $11.20 | General |
| Category: Treatment of ACNE Vulgaris | ||||||
| 12/01/2020 | VYNE Pharmaceuticals Inc. | ZILXI (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Treatment of Rosacea | ||||||
| 11/17/2020 | VYNE Pharmaceuticals Inc. | ZILXI (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Treatment of Rosacea | ||||||
| 11/04/2020 | LEO Pharma Inc. | ENSTILAR (Drug) | Food and Beverage | In-kind items and services | $11.90 | General |
| Category: DERMATOLOGY | ||||||
| 11/03/2020 | VYNE Pharmaceuticals Inc. | ZILXI (Drug) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: Treatment of Rosacea | ||||||
| 09/22/2020 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $99.00 | General |
| Category: Immunology | ||||||
| 08/26/2020 | VYNE Pharmaceuticals Inc. | AMZEEQ (Drug) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Treatment of ACNE Vulgaris | ||||||
| 02/11/2020 | VYNE Pharmaceuticals Inc. | AMZEEQ (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: Treatment of ACNE Vulgaris | ||||||
| 06/10/2019 | AbbVie, Inc. | Humira (Biological), Skyrizi | Food and Beverage | In-kind items and services | $22.12 | General |
| Category: Immunology | ||||||
| 05/08/2019 | Galderma Laboratories, L.P. | ORACEA (Drug) | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: ROSACEA | ||||||
| 04/05/2019 | Janssen Biotech, Inc. | Tremfya (Drug) | Education | In-kind items and services | $79.99 | General |
| Category: Immunology | ||||||
| 12/07/2018 | Merz North America, Inc. | XEOMIN | Food and Beverage | Cash or cash equivalent | $162.85 | General |
| 07/24/2018 | Janssen Biotech, Inc. | Tremfya (Drug) | Education | In-kind items and services | $99.99 | General |
| Category: Immunology | ||||||
| 04/10/2018 | Ortho Dermatologics, a division of Bausch Health US, LLC | SILIQ (Drug), ELIDEL, ONEXTON | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: DERMATOLOGY | ||||||
| 04/04/2018 | Allergan Inc. | — | Food and Beverage | In-kind items and services | $21.19 | General |
| 12/11/2017 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: Immunology | ||||||
| 07/28/2017 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $116.81 | General |
| Category: DERMATOLOGY | ||||||
| 05/02/2017 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: Immunology | ||||||
| 03/22/2017 | Janssen Biotech, Inc. | STELARA (Biological) | Education | In-kind items and services | $99.00 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 35 | 2,948 | 3,992 | $811,067 | $275,452 |
| 2022 | 33 | 2,895 | 3,986 | $787,122 | $283,886 |
| 2021 | 29 | 2,968 | 4,017 | $774,969 | $295,736 |
| 2020 | 31 | 2,924 | 3,950 | $729,026 | $260,010 |
Total Patients
11,735
Total Services
15,945
Medicare Billing
$1.1M
Procedure Codes
128
All Medicare Procedures & Services
128 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 103 | 109 | $127,966 | $54,048 | 42.2% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 646 | 1,056 | $180,576 | $48,970 | 27.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 629 | 745 | $119,200 | $41,127 | 34.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 343 | 422 | $51,484 | $15,647 | 30.4% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 63 | 63 | $31,752 | $13,828 | 43.5% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 29 | 40 | $25,880 | $12,460 | 48.1% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2023 | 34 | 37 | $20,350 | $9,649 | 47.4% |
| 12052 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | Office | 2023 | 52 | 52 | $25,220 | $9,222 | 36.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 88 | 92 | $17,480 | $7,292 | 41.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 95 | 101 | $16,665 | $6,225 | 37.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 78 | 78 | $14,820 | $5,140 | 34.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 123 | 128 | $15,985 | $4,821 | 30.2% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 45 | 55 | $13,695 | $4,566 | 33.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 51 | 59 | $10,089 | $4,346 | 43.1% |
| 12051 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.5 cm or less | Office | 2023 | 21 | 21 | $9,324 | $4,097 | 43.9% |
| 12042 | Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm | Office | 2023 | 19 | 19 | $10,431 | $3,959 | 38.0% |
| 96567 | Application of light to destroy precancer skin growth | Office | 2023 | 34 | 37 | $11,951 | $3,861 | 32.3% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 31 | 32 | $11,264 | $3,488 | 31.0% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 37 | 37 | $16,095 | $3,131 | 19.5% |
| 17281 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 20 | 24 | $9,168 | $2,986 | 32.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 188 | 552 | $13,800 | $2,407 | 17.4% |
| 11642 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 20 | 20 | $11,480 | $1,770 | 15.4% |
| 17271 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | Office | 2023 | 15 | 17 | $4,879 | $1,519 | 31.1% |
| 11622 | Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 16 | 16 | $7,248 | $1,429 | 19.7% |
| 17280 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less | Office | 2023 | 16 | 17 | $4,794 | $1,274 | 26.6% |
About Dr. William Andersen, MD
Dr. William Andersen, MD is a Dermatology healthcare provider based in Lancaster, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1538135900.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Andersen, MD has received a total of $1,310 in payments from pharmaceutical and medical device companies, with $115.60 received in 2024. These payments were reported across 25 transactions from 10 companies. The most common payment nature is "Education" ($754.97).
As a Medicare-enrolled provider, Andersen has provided services to 11,735 Medicare beneficiaries, totaling 15,945 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 128 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Other Specialties Dermatopathology, Anatomic Pathology & Clinical Pathology
- Location Lancaster, PA
- Active Since 02/27/2006
- Last Updated 12/07/2007
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1538135900
Products in Payments
- TREMFYA (Drug) $475.99
- Tremfya (Drug) $179.98
- EUCRISA (Drug) $116.81
- STELARA (Biological) $99.00
- Humira (Biological) $57.11
- ZILXI (Drug) $49.15
- AMZEEQ (Drug) $39.24
- ORACEA (Drug) $22.04
- Xtandi (Drug) $16.60
- SILIQ (Drug) $13.78
- ENSTILAR (Drug) $11.90
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Lancaster
Dario Kivelevitch, M.d, M.D
Dermatology — Payments: $183,858
Dermatology $183,858
Dr. William Groff, D.o, D.O
Dermatology — Payments: $30,946
Dermatology $30,946
Farhan Huq, Md, MD
Dermatology — Payments: $6,870
Dermatology $6,870
Amanda Conroy, Crnp, CRNP
Dermatology — Payments: $3,355
Dermatology $3,355
Michael Duffey, M.d, M.D
Dermatology — Payments: $2,935
Dermatology $2,935
Arvin Doostan, Md, MD
Dermatology — Payments: $1,507
Dermatology $1,507